© Reuters. FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/
BERLIN (Reuters) – Germany’s IGBCE union opposes any splitting-up of Bayer (ETR:) after the departure of its chief executive, taz newspaper reported on Thursday.
“From the point of view of the employees, Bayer with its three pillars is perfectly positioned for the challenges of the future,” said IGBCE executive board member Francesco Grioli, who is also a member of the supervisory board at Bayer.
Bayer announced on Wednesday that it was replacing its CEO early, recruiting the former head of Roche’s pharmaceuticals business, as investor criticism over the company’s lacklustre share price grew.
